BULLETIN V2026-1940
THERALASE TECHNOLOGIES INC. ("TLT") ("TLT.WT")
BULLETIN TYPE: Private Placement- Brokered, New Listing-Warrants
BULLETIN DATE: June 5, 2026
TSX Venture Tier 2 Company
Financing Type: Brokered Private Placement (LIFE Offering).
Gross Proceeds: $4,600,000.08
Offering: 19,166,667 Units. Each Unit comprised of 1 Listed Share and 1 Warrant.
Offering Price: $0.24 per Unit
Warrant Exercise Terms: $0.32 per Listed Share until May 20, 2031
Overallotment Option: The underwriters exercised the over-allotment option in full. All information presented herein includes such exercise.
Commissions in Securities: The brokers received 1,232,383 Broker warrants for their services rendered.
Broker Warrants:
#Broker Warrants
(Aggregate # of Brokers: 1) 1,232,383
Broker Warrant Terms: Each Broker Warrant is non-transferable and exercisable into one Unit at $0.24 until May 20, 2031.
Listing of Warrants:
Effective at the opening on Tuesday, June 9, 2026, the Warrants of the Company will commence trading on TSX Venture Exchange. The Company is classified as an 'Medical Device Development' company.
Corporate Jurisdiction: Ontario
Capitalization: Up to 20,399,050 Warrants, authorized by a Warrant Indenture dated May 20, 2026, of which 19,166,667 Warrants are issued and outstanding.
Warrants Exercise Terms: Each Warrant entitles the holder thereof to acquire one (1) Listed Share at an exercise price of $0.32 per Listed Share, until May 20, 2031.
Transfer Agent: TSX Trust Company
Trading Symbol: TLT.WT
CUSIP Number: 88337V142
Disclosure: Refer to the offering document dated May 5, 2026 and company's news release(s) dated May 5, 2026, May 20, 2026 and June 3, 2026.
_______________________________________
|
|
